367 related articles for article (PubMed ID: 30806090)
1. Angiotensin-converting enzyme 2 activation suppresses pulmonary vascular remodeling by inducing apoptosis through the Hippo signaling pathway in rats with pulmonary arterial hypertension.
Yan D; Li G; Zhang Y; Liu Y
Clin Exp Hypertens; 2019; 41(6):589-598. PubMed ID: 30806090
[No Abstract] [Full Text] [Related]
2. Angiotensin-converting enzyme 2 activation ameliorates pulmonary endothelial dysfunction in rats with pulmonary arterial hypertension through mediating phosphorylation of endothelial nitric oxide synthase.
Li G; Zhang H; Zhao L; Zhang Y; Yan D; Liu Y
J Am Soc Hypertens; 2017 Dec; 11(12):842-852. PubMed ID: 29146157
[TBL] [Abstract][Full Text] [Related]
3. ACE2 activation confers endothelial protection and attenuates neointimal lesions in prevention of severe pulmonary arterial hypertension in rats.
Li G; Liu Y; Zhu Y; Liu A; Xu Y; Li X; Li Z; Su J; Sun L
Lung; 2013 Aug; 191(4):327-36. PubMed ID: 23652350
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Siah2 ubiquitin ligase ameliorates monocrotaline-induced pulmonary arterial remodeling through inactivation of YAP.
Wang Q; Shi W; Zhang Q; Feng W; Wang J; Zhai C; Yan X; Li M
Life Sci; 2020 Feb; 242():117159. PubMed ID: 31837334
[TBL] [Abstract][Full Text] [Related]
5. Magnolol ameliorates pneumonectomy and monocrotaline-induced pulmonary arterial hypertension in rats through inhibition of angiotensin II and endothelin-1 expression.
Chang H; Chang CY; Lee HJ; Chou CY; Chou TC
Phytomedicine; 2018 Dec; 51():205-213. PubMed ID: 30466619
[TBL] [Abstract][Full Text] [Related]
6. Thymoquinone attenuates monocrotaline-induced pulmonary artery hypertension via inhibiting pulmonary arterial remodeling in rats.
Zhu N; Zhao X; Xiang Y; Ye S; Huang J; Hu W; Lv L; Zeng C
Int J Cardiol; 2016 Oct; 221():587-96. PubMed ID: 27420584
[TBL] [Abstract][Full Text] [Related]
7. Baicalein attenuates monocrotaline-induced pulmonary arterial hypertension by inhibiting vascular remodeling in rats.
Shi R; Wei Z; Zhu D; Fu N; Wang C; Yin S; Liang Y; Xing J; Wang X; Wang Y
Pulm Pharmacol Ther; 2018 Feb; 48():124-135. PubMed ID: 29133079
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme 2 activation protects against pulmonary arterial hypertension through improving early endothelial function and mediating cytokines levels.
Li G; Xu YL; Ling F; Liu AJ; Wang D; Wang Q; Liu YL
Chin Med J (Engl); 2012 Apr; 125(8):1381-8. PubMed ID: 22613639
[TBL] [Abstract][Full Text] [Related]
9. Losartan attenuates chronic cigarette smoke exposure-induced pulmonary arterial hypertension in rats: possible involvement of angiotensin-converting enzyme-2.
Han SX; He GM; Wang T; Chen L; Ning YY; Luo F; An J; Yang T; Dong JJ; Liao ZL; Xu D; Wen FQ
Toxicol Appl Pharmacol; 2010 May; 245(1):100-7. PubMed ID: 20178811
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of FGFR Signaling With PD173074 Ameliorates Monocrotaline-induced Pulmonary Arterial Hypertension and Rescues BMPR-II Expression.
Zheng Y; Ma H; Hu E; Huang Z; Cheng X; Xiong C
J Cardiovasc Pharmacol; 2015 Nov; 66(5):504-14. PubMed ID: 26535780
[TBL] [Abstract][Full Text] [Related]
11. Rapamycin reduced pulmonary vascular remodelling by inhibiting cell proliferation via Akt/mTOR signalling pathway down-regulation in the carotid artery-jugular vein shunt pulmonary hypertension rat model.
Ma X; Yao J; Yue Y; Du S; Qin H; Hou J; Wu Z
Interact Cardiovasc Thorac Surg; 2017 Aug; 25(2):206-211. PubMed ID: 28475806
[TBL] [Abstract][Full Text] [Related]
12. Noncanonical HIPPO/MST Signaling via BUB3 and FOXO Drives Pulmonary Vascular Cell Growth and Survival.
Kudryashova TV; Dabral S; Nayakanti S; Ray A; Goncharov DA; Avolio T; Shen Y; Rode A; Pena A; Jiang L; Lin D; Baust J; Bachman TN; Graumann J; Ruppert C; Guenther A; Schmoranzer M; Grobs Y; Eve Lemay S; Tremblay E; Breuils-Bonnet S; Boucherat O; Mora AL; DeLisser H; Zhao J; Zhao Y; Bonnet S; Seeger W; Pullamsetti SS; Goncharova EA
Circ Res; 2022 Mar; 130(5):760-778. PubMed ID: 35124974
[TBL] [Abstract][Full Text] [Related]
13. Salvianolic acid A attenuates vascular remodeling in a pulmonary arterial hypertension rat model.
Chen YC; Yuan TY; Zhang HF; Wang DS; Yan Y; Niu ZR; Lin YH; Fang LH; Du GH
Acta Pharmacol Sin; 2016 Jun; 37(6):772-82. PubMed ID: 27180980
[TBL] [Abstract][Full Text] [Related]
14. A novel ACE2 activator reduces monocrotaline-induced pulmonary hypertension by suppressing the JAK/STAT and TGF-β cascades with restored caveolin-1 expression.
Haga S; Tsuchiya H; Hirai T; Hamano T; Mimori A; Ishizaka Y
Exp Lung Res; 2015 Feb; 41(1):21-31. PubMed ID: 25275723
[TBL] [Abstract][Full Text] [Related]
15. Tsantan Sumtang attenuated chronic hypoxia-induced right ventricular structure remodeling and fibrosis by equilibrating local ACE-AngII-AT1R/ACE2-Ang1-7-Mas axis in rat.
Dang Z; Su S; Jin G; Nan X; Ma L; Li Z; Lu D; Ge R
J Ethnopharmacol; 2020 Mar; 250():112470. PubMed ID: 31862407
[TBL] [Abstract][Full Text] [Related]
16. Tetrandrine prevents monocrotaline-induced pulmonary arterial hypertension in rats through regulation of the protein expression of inducible nitric oxide synthase and cyclic guanosine monophosphate-dependent protein kinase type 1.
Wang X; Yang Y; Yang D; Tong G; Lv S; Lin X; Chen C; Dong W
J Vasc Surg; 2016 Nov; 64(5):1468-1477. PubMed ID: 26527422
[TBL] [Abstract][Full Text] [Related]
17. Betaine Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats via Inhibiting Inflammatory Response.
Yang JM; Zhou R; Zhang M; Tan HR; Yu JQ
Molecules; 2018 May; 23(6):. PubMed ID: 29861433
[TBL] [Abstract][Full Text] [Related]
18. Calorie Restriction Attenuates Monocrotaline-induced Pulmonary Arterial Hypertension in Rats.
Ding M; Lei J; Qu Y; Zhang H; Xin W; Ma F; Liu S; Li Z; Jin F; Fu E
J Cardiovasc Pharmacol; 2015 Jun; 65(6):562-70. PubMed ID: 25636073
[TBL] [Abstract][Full Text] [Related]
19. Betaine alleviates right ventricular failure via regulation of Rho A/ROCK signaling pathway in rats with pulmonary arterial hypertension.
Lv Y; Ma P; Wang J; Xu Q; Fan J; Yan L; Ma P; Zhou R
Eur J Pharmacol; 2021 Nov; 910():174311. PubMed ID: 34245749
[TBL] [Abstract][Full Text] [Related]
20. Formononetin attenuates monocrotaline‑induced pulmonary arterial hypertension via inhibiting pulmonary vascular remodeling in rats.
Cai C; Xiang Y; Wu Y; Zhu N; Zhao H; Xu J; Lin W; Zeng C
Mol Med Rep; 2019 Dec; 20(6):4984-4992. PubMed ID: 31702810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]